Demant A/S
Short position disclosed on May 18, 2026.
1.89% of the capital sold short
2 disclosing funds
261 disclosures on record
DK0060738599 ISIN code
Evolution of the disclosed total
0%0.5%1%1.5%2%
Oct 2025Jan 2026Apr 2026Jul 2026
January 30, 2015 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| AQR Capital Management, LLC | 1.30% | new | April 14, 2026 | |
| Marshall Wace LLP | 0.59% | new | May 18, 2026 |
On the other side: the funds that hold Demant A/S Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 13, 2015 | BlackRock Institutional Trust Company | 0.50% | August 13, 2015 |
| July 10, 2015 | Millennium International Management LP | 0.49% | July 10, 2015 |
| July 10, 2015 | OCH-ZIFF Management Europe Limited | 0.45% | July 10, 2015 |
| June 18, 2015 | OCH-ZIFF Management Europe Limited | 0.59% | June 18, 2015 |
| June 16, 2015 | OCH-ZIFF Management Europe Limited | 0.66% | June 16, 2015 |
| June 9, 2015 | Millennium International Management LP | 0.50% | June 9, 2015 |
| May 13, 2015 | OCH-ZIFF Management Europe Limited | 0.71% | May 13, 2015 |
| April 24, 2015 | OCH-ZIFF Management Europe Limited | 0.65% | April 24, 2015 |
| April 23, 2015 | OCH-ZIFF Management Europe Limited | 0.54% | April 23, 2015 |
| April 10, 2015 | OCH-ZIFF Management Europe Limited | 0.46% | April 10, 2015 |
| January 30, 2015 | OCH-ZIFF Management Europe Limited | 0.53% | January 30, 2015 |
Other companies sold short in Denmark
- Zealand Pharma A/S 6.75% of the capital sold short
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
- Coloplast A/S 0.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Demant A/S, source Finanstilsynet, data as at May 18, 2026, https://www.quivad.com/action/demant-a-s?page=6